Small Pharmaceuticals

Alembic Pharmaceuticals Ltd.

APLLTD

Market Cap
₹16,710 Cr.
P/E
24.76

Alembic Pharmaceuticals Ltd.

  • Alembic Pharma
  • Jubilant Pharmova
  • Natco Pharma
  • TJI Pharma

FAQs on Alembic Pharmaceuticals Ltd. Shareprice

Alembic Pharma has given lower returns compared to its competitors.
Alembic Pharma has grown at ~4.64% over the last 9yrs while peers have grown at a median rate of 9.72%

Alembic Pharma is not expensive.
Latest PE of Alembic Pharma is 23.92, while 3 year average PE is 30.93.
Also latest EV/EBITDA of Alembic Pharma is 15.46 while 3yr average is 18.7.

View FAQ's On Business

Growth Table

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Natco Pharma

Balance Sheet

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Natco Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Natco Pharma

Cash Flow

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Natco Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Natco Pharma

Quarterly Results

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Natco Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Alembic Pharmaceuticals Ltd. Financials

Balance sheet of Alembic Pharma is strong.
But short term working capital might become an issue for this company.

The net debt of Alembic Pharma is decreasing.
Latest net debt of Alembic Pharma is ₹956 Crs as of Mar-26.
This is less than Mar-25 when it was ₹1,016 Crs.

The profit is oscillating.
The profit of Alembic Pharma is ₹675 Crs for Mar 2026, ₹583 Crs for Mar 2025 and ₹616 Crs for Mar 2024

The company seems to pay a good stable dividend.
Alembic Pharma latest dividend payout ratio is 34.95% and 3yr average dividend payout ratio is 35.71%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech